Currently, agents that specifically target CDK5 hyperactivity in ischemic stroke are scarce, but TFP5 has potential to serve as a CDK5-targeting agent and might also be used as an agent in co-treatments for ischemic stroke. Here, CDK5 is linked to ischemic stroke.